Northern Trust’s Fennec Pharmaceuticals FENC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.09M | Sell |
131,472
-6,903
| -5% | -$57.3K | ﹤0.01% | 3334 |
|
|
2025
Q1 | $843K | Buy |
138,375
+1,620
| +1% | +$9.87K | ﹤0.01% | 3353 |
|
|
2024
Q4 | $864K | Sell |
136,755
-2,976
| -2% | -$18.8K | ﹤0.01% | 3456 |
|
|
2024
Q3 | $699K | Buy |
139,731
+33,332
| +31% | +$167K | ﹤0.01% | 3476 |
|
|
2024
Q2 | $650K | Sell |
106,399
-7,669
| -7% | -$46.9K | ﹤0.01% | 3407 |
|
|
2024
Q1 | $1.27M | Buy |
114,068
+2,308
| +2% | +$25.7K | ﹤0.01% | 3207 |
|
|
2023
Q4 | $1.25M | Buy |
111,760
+897
| +0.8% | +$10.1K | ﹤0.01% | 3234 |
|
|
2023
Q3 | $833K | Sell |
110,863
-3,620
| -3% | -$27.2K | ﹤0.01% | 3357 |
|
|
2023
Q2 | $1.01M | Buy |
+114,483
| New | +$1.01M | ﹤0.01% | 3358 |
|
|
2021
Q2 | – | Sell |
-182,107
| Closed | -$1.13M | – | 4607 |
|
|
2021
Q1 | $1.13M | Sell |
182,107
-21,892
| -11% | -$136K | ﹤0.01% | 3532 |
|
|
2020
Q4 | $1.52M | Sell |
203,999
-2,635
| -1% | -$19.6K | ﹤0.01% | 3332 |
|
|
2020
Q3 | $1.25M | Sell |
206,634
-10,226
| -5% | -$62K | ﹤0.01% | 3290 |
|
|
2020
Q2 | $1.81M | Buy |
+216,860
| New | +$1.81M | ﹤0.01% | 3090 |
|
|
2019
Q3 | – | Sell |
-96,972
| Closed | -$388K | – | 4265 |
|
|
2019
Q2 | $388K | Sell |
96,972
-5,105
| -5% | -$20.4K | ﹤0.01% | 3624 |
|
|
2019
Q1 | $495K | Buy |
102,077
+220
| +0.2% | +$1.07K | ﹤0.01% | 3540 |
|
|
2018
Q4 | $650K | Sell |
101,857
-228
| -0.2% | -$1.46K | ﹤0.01% | 3496 |
|
|
2018
Q3 | $837K | Buy |
102,085
+753
| +0.7% | +$6.17K | ﹤0.01% | 3517 |
|
|
2018
Q2 | $1.06M | Buy |
+101,332
| New | +$1.06M | ﹤0.01% | 3441 |
|